Nisa Investment Advisors
KURA icon

Nisa Investment Advisors’s Kura Oncology KURA Stock Holding History

Nisa Investment Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
2,851
+2,668
+1,458% +$25.2K ﹤0.01% 2044
2026
Q1 		$1.49K Hold
183
– – ﹤0.01% 2668
2025
Q4 		$1.9K Sell
183
-940
-84% -$9.86K ﹤0.01% 2615
2025
Q3 		$9.94K Buy
1,123
+149
+15% +$1.06K ﹤0.01% 2283
2025
Q2 		$5.62K Sell
974
-822
-46% -$5.04K ﹤0.01% 2425
2025
Q1 		$11.9K Buy
1,796
+806
+81% +$6.28K ﹤0.01% 2057
2024
Q4 		$8.62K Sell
990
-146
-13% -$2.1K ﹤0.01% 2166
2024
Q3 		$22.2K Buy
1,136
+12
+1% +$243 ﹤0.01% 1882
2024
Q2 		$23.1K Buy
1,124
+64
+6% +$1.32K ﹤0.01% 1895
2024
Q1 		$22.6K Buy
1,060
+70
+7% +$1.36K ﹤0.01% 1849
2023
Q4 		$14.2K Buy
990
+16
+2% +$157 ﹤0.01% 1962
2023
Q3 		$8.88K Sell
974
-15
-2% -$152 ﹤0.01% 2194
2023
Q2 		$10.5K Sell
989
-1,336
-57% -$15.8K ﹤0.01% 2250
2023
Q1 		$28K Buy
2,325
+1,385
+147% +$17.3K ﹤0.01% 1901
2022
Q4 		$12K Sell
940
-53
-5% -$770 ﹤0.01% 2169
2022
Q3 		$15K Sell
993
-2,297
-70% -$35.4K ﹤0.01% 2112
2022
Q2 		$60K Buy
3,290
+1,470
+81% +$21.1K ﹤0.01% 1676
2022
Q1 		$29K Buy
1,820
+1,220
+203% +$17.6K ﹤0.01% 1977
2021
Q4 		$8K Hold
600
– – ﹤0.01% 2054
2021
Q3 		$11K Hold
600
– – ﹤0.01% 2192
2021
Q2 		$13K Sell
600
-2,250
-79% -$55.9K ﹤0.01% 2192
2021
Q1 		$81K Sell
2,850
-375
-12% -$11.9K ﹤0.01% 1839
2020
Q4 		$105K Buy
3,225
+1,075
+50% +$37.8K ﹤0.01% 1716
2020
Q3 		$66K Buy
+2,150
New +$47.5K ﹤0.01% 1695

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Nisa Investment Advisors's KURA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Kura Oncology (KURA) stake by 1,458% in Q2 2026, buying an estimated $25.2K and bringing the position to 2,851 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Nisa Investment Advisors first reported a position in KURA in Q3 2020 and has held it in 24 quarters since. The position peaked at $105K in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Nisa Investment Advisors held 2,851 shares of Kura Oncology worth $31.3K as of Q2 2026.
  • Nisa Investment Advisors bought 2,668 Kura Oncology shares in Q2 2026, an estimated $25.2K.
  • Kura Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2044 holding.
  • Nisa Investment Advisors first reported a position in Kura Oncology in Q3 2020 and has held it in 24 quarters since.
  • Nisa Investment Advisors's Kura Oncology position peaked at $105K in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.